Bronchitis%20-%20chronic%20in%20acute%20exacerbation Management

Management

Prevention

Influenza Vaccine

The use of an annual influenza vaccine for all patients with chronic bronchitis is strongly recommended
- Patients with chronic lung disease have a higher risk of complications from influenza infection
- Annual influenza vaccination decreases the morbidity and mortality of influenza in the elderly by 50%
Please see Influenza disease management chart for further information

Pneumococcal Vaccine

It is recommended that pneumococcal vaccine be administered at least once to patients with chronic bronchitis
- Consider repeating vaccine every 5-10 years in high-risk patients
Pneumococcal vaccine is safe and may reduce invasive pneumococcal infection in patients with COPD

Coronavirus Disease 2019 (COVID-19) Vaccine

Highly effective against SARS-CoV-2 infection
Chronic bronchitis is commonly seen in patients with COPD
Patients with underlying medical conditions and smokers are at higher risk for severe COVID-19 outcomes
Please see Coronavirus Disease 2019 (COVID-19) disease management chart for further information

Product Highlight - ZAVICEFTA

12 Sep 2023

Ceftazidime 2 g, avibactam 0.5 g powder for concentrate for solution for infusion

New asthma guide: What doctors should know

Pearl Toh, 26 Nov 2020

Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.

Current management of nosocomial and community-acquired pneumonia in ICU patients with novel antibiotics

Prof. Andrew Shorr, 27 Aug 2021

Nosocomial pneumonia serves as a paradigm for all severe infections, and appropriate antibiotic therapy is the key determinant of patient outcomes. Most data for the use of antibiotics are derived from studies in non-ICU patients and ignore critical care issues such as fluid resuscitation, mechanical ventilation, and changing renal function. Against the backdrop of increasing antimicrobial resistance and the COVID-19 pandemic, how do we optimize antibiotic administration in the ICU? Professor Andrew Shorr from Washington Hospital Center, Georgetown University, Washington DC, US discussed this burning issue at a Pfizer-sponsored satellite symposium, held during the Asia Pacific Intensive Care Symposium (APICS) 2021.